484 Results (Page 17 of 20)
UAE Markets Research Reports
UAE 3D Imaging Market Analysis
The UAE 3D imaging market is projected to grow from $0.15 Bn in 2022 to $0.55 Bn by 2030, registering a CAGR of 17.5% during the forecast period of 2022-30. The market will be driven by expanding healthcare investments and rising demand for improved medical services. The market is segmented by product, application, end-user & by portability. Some of the major players include GE Healthcare, Philips Healthcare & Siemens Healthineers.
UAE Diabetes Devices Market Analysis
The UAE Diabetes Devices Market is expected to witness growth from $114 Mn in 2022 to $213 Mn in 2030 with a CAGR of 8.20% for the forecasted year 2022-2030. The high prevalence of diabetes, the quick uptake of novel products, increased R&D efforts, and the raising awareness of diabetes preventive care are some major market drivers for diabetes devices in the UAE. The market is segmented by type and by the end user. Some key players in this market include Mecomed, Pioneer Medical Supplies, Johnson & Johnson, Philipps Healthcare, Medtronic, DSM N.V., Roche and Dexcom.
UAE ECG Equipments Market Analysis
The UAE ECG Equipment Market is expected to witness growth from $45 Mn in 2022 to $84 Mn in 2030 with a CAGR of 8.30% for the forecasted year 2022-2030. One of the major reasons propelling the expansion of the ECG equipment market is the rising prevalence of cardiac diseases in the United Arab Emirates. The market is segmented by product type and by the end user. Some key players in this market include Winray, Mena Medical Supplies, Johnson & Johnson, Philipps Healthcare, Medtronic, DSM N.V., Roche and Dexcom.
UAE 3D Printing Medical Devices Market Analysis
UAE 3D printing medical device Market is expected to witness growth from $15 Mn in 2022 to $53 Mn in 2030 with a CAGR of 17.30% for the forecasted year 2022-30. Increasing demand for customized medical devices in the United Arab Emirates, technological advancements, rising healthcare spending, and rising awareness of 3D printing technology are some of the major market growth factors for makers in this sector. The market is segmented by product segmented by application, technology, and end user. Some key players in this market include Bin Ali Medical Supplies, Immensa Technology Labs, Proto21, GE Healthcare, Stryker, and Medtronic.
UAE Liver Cancer Therapeutics Market Analysis
By 2030, it is anticipated that the UAE liver cancer therapeutics market will reach a value of $57.3 Mn from $14.7 Mn in 2022, growing at a CAGR of 18.6% during 2022-30. The liver cancer therapeutics in UAE is dominated by a few domestic pharmaceutical companies such as Neopharma, Julphar, and Medpharma. The liver cancer therapeutics market in UAE is segmented into different types of cancer and different therapy type. Some of the major factors affecting this market are the growing prevalence of liver cancer and the high cost and side effects related to certain liver cancer therapies.
UAE Lung Cancer Therapeutics Market Analysis
By 2030, it is anticipated that the UAE Lung Cancer Therapeutics Market will reach a value of $299 Mn from $149 Mn in 2022, growing at a CAGR of 9.1% during 2022-2030. The Lung Cancer Therapeutics Market in UAE is dominated by a few domestic pharmaceutical companies such as Gulf Pharmaceutical Industries, Neopharma, and SITCO. The Lung Cancer Therapeutics Market in UAE is segmented into different types of cancer and different therapy type. Some of the major factors affecting the UAE lung cancer therapeutics market are the prevalence of unhealthy lifestyles, demand for targeted therapies and the presence of highly efficient drugs.
UAE Oncology Therapeutics Market Analysis
By 2030, it is anticipated that the UAE Oncology Therapeutics Market will reach a value of $1.8 Bn from $0.91 Bn in 2022, growing at a CAGR of 9.4% during 2022-2030. The Oncology Therapeutics Market in UAE is dominated by a few domestic pharmaceutical companies such as Neopharma, Medpharma, and Julphar. The Oncology Therapeutics Market in UAE is segmented into different types of cancer and different therapy type. The major risk factors associated with cancer are diet, alcohol, tobacco, air pollution, and physical inactivity. The demand for UAE Oncology Therapeutics is increasing on account of the rise in initiatives taken by the Government of the country.
UAE Cardiac Surgery Instruments Market Analysis
The UAE Cardiac Surgery Instruments Market is expected to witness growth from $10 Mn in 2022 to $19 Mn in 2030 with a CAGR of 7.60% for the forecasted year 2022-2030. The UAE has gained popularity as a destination for medical tourism, especially among patients seeking high-quality treatment at a lower cost. As a result, there is now greater demand for cardiac surgery instruments. The market is segmented by type, application and by end user. Some key players in this market include Gulf Scientific Al Mazroui Medical and Chemical Supplies, LivaNova, B. Braun, Medline Industries, KLS Martin, and STILLE.
UAE Anti Aging Therapeutics Market Analysis
UAE anti-aging therapeutics market is projected to grow from $3 Mn in 2022 to $11 Mn in 2030 with a CAGR of 17.53% for the year 2022-2030. The market is projected to expand as a result of the growing demand for anti-aging treatments and rising disposable incomes in the UAE. The UAE anti-aging therapeutics market is segmented by product, treatment, target group, type of aging, type of molecules, mechanism of action, ingredient, and by distribution channel. Insilico Medicine, Kuwait Saudi Pharmaceuticals, and Alkahest are the top players in the market.
UAE Biomaterials in Healthcare Market Analysis
The UAE Biomaterials in Healthcare Market is expected to witness growth from $781 Mn Bn in 2022 to $2260 Mn in 2030 with a CAGR of 14.20% for the forecasted year 2022-2030. The demand for biomaterials, is rising in UAE as the population increases. As a result, there are now chances for manufacturers of biomaterials to diversify their product lines and grow their market share. The market is segmented by type and by application. Some key players in this market include: Julphar, Mena Medical Supplies, Mena Medical Supplies, BASF SE, Johnson and Johnson, Medtronic and Evonik Industries.
UAE Healthcare Claims Management Market Analysis
The UAE healthcare claims management market is projected to grow from $133.5 Mn in 2022 to $765.67 Mn by 2030, registering a CAGR of 24.4% during the forecast period of 2022 - 2030. The main factors driving the growth would be mandatory health insurance, emphasis on quality healthcare and technological advancements. The market is segmented by component, type, delivery mode and by end-user. Some of the major players include NAS Neuron Health Services, Nextcare, Aafiya, Optum, GE Healthcare and Cognizant.
UAE ADHD (Attention Deficit Hyperactivity Disorder) Therapeutic Market Analysis
UAE's Attention Deficit Hyperactivity Disorder (ADHD) therapeutics market is projected to grow from $148 Mn in 2022 to $284 Mn in 2030 with a CAGR of 8.5% for the year 2022-30. More cases of ADHD being diagnosed in children and UAE and the development of health infrastructure in UAE are the main market drivers. The UAE ADHD therapeutics market is segmented by drug, drug type, demographics, and by distribution channel. Join Hub Gulf Pharma, Genpharm, and Eli Lilly are some of the key players in the market.
UAE Healthcare Financial Analytics Market Analysis
The UAE Healthcare Financial Analytics market size was valued at $xx Mn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 7.8% from 2022 to 2030 and will reach $xx Mn in 2030. The market is segmented by type, component, and deployment. UAE’s Healthcare Financial Analytics market will grow as rising healthcare costs, increasing demand for better patient outcomes, and the growing adoption of digital technologies in healthcare. The key market players are Healthbit, Pulsus Healthtech, Fórmula Médica, Kryptus, and others.
UAE Liver Diseases Therapeutics Market Analysis
By 2030, it is anticipated that the UAE Liver Disease Therapeutics market will reach a value of $194 Mn from $115 Mn in 2022, growing at a CAGR of 6.7% during 2022-2030. Liver Disease Therapeutics in UAE is dominated by domestic pharmaceutical companies such as Global pharma, Neopharma, and Julphar. The Liver Disease Therapeutics market in UAE is segmented into different types of disease and different therapy types. Some of the significant factors affecting the UAE Liver Disease Therapeutics market are the growing prevalence of liver diseases and unhealthy and dynamic lifestyles.
UAE Oncology Clinical Trials Market Analysis
The UAE oncology clinical trials market is projected to grow from $63.3 Mn in 2022 to $104.7 Mn by 2030, registering a CAGR of 6.5% during the forecast period of 2022-30. The market will be driven by the rising rate of cancer in the UAE and investments in developing healthcare infrastructure and research capabilities to support the field. The market is segmented by phase, study design, and indication. Some of the major players include Pfizer Inc, FHoffmann-La Roche Ltd & Julphar
UAE Diabetes Drugs Market Analysis
The UAE diabetes drugs market size was valued at $308.97 Mn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 7.1% from 2022 to 2030 and will reach $535 Mn in 2030. The market is segmented by drug type, application, and distribution channel. The UAE diabetes drug market will grow as the UAE government's initiatives to address the diabetes epidemic. The key market players are Neopharma (UAE), Julphar (Gulf Pharmaceutical Industries), Boehringer Ingelheim, and others.
UAE Anemia Drugs Market Analysis
The UAE Anemia drugs market was valued at $80 Mn in 2022 and is estimated to expand at a CAGR of 9.9% from 2022-30 and will reach $170 Mn in 2030. One of the main reasons propelling the growth of this market is the introduction of newer technologies, and the aging population. The market is segmented by type, drug, and distribution channel. Some key players in this market are Life Pharma, Neo Pharma, New Bridge Pharmaceuticals, Sahara pharmaceutical, GlaxoSmithKline, GlycoMimetics, and Amgen among others.
UAE Alzheimer’s Disease Drugs Market Analysis
UAE Alzheimer’s Disease Drugs market was valued at $77 Mn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 9.42% from 2022 to 2030 and will reach $158 Mn in 2030. One of the main reasons propelling the growth of this market is the introduction of newer technologies, and the aging population. The market is segmented by drug classes and by Distribution Channels. Some key players in this market are Julphar, Lundbeck, Eisai Co., Eli Lilly and Company, Johnson and Johnson, H. Lundbeck A/S, Roche, Merck & Co., Novartis, Pfizer, and Teva Pharmaceutical among others.
UAE Infectious Disease Therapeutics Market Analysis
By 2030, it is anticipated that the UAE infectious disease therapeutics market will reach a value of $909.4 Mn from $599.35 Mn in 2022, growing at a CAGR of 5.4% during 2022-2030. The Infectious Disease Therapeutics in UAE is dominated by a few domestic pharmaceutical companies such as Medpharma, Julphar and Neopharma. The Infectious Disease Therapeutics market in UAE is segmented into different therapeutic areas and different diseases type. The major factors affecting the UAE infectious disease therapeutics market are the increasing disease burden of communicable diseases like TB, hepatitis, and COVID-19 and the amount of healthcare funding for infectious diseases treatment in various the areas of UAE.
UAE Teleradiology Market Analysis
The UAE Teleradiology market size was valued at $12 Mn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 12.7% from 2022 to 2030 and will reach $ 31 Mn in 2030. The market is segmented by application, modality, technology solutions, and end user. Teleradiology is becoming increasingly popular in UAE due to the growing demand for remote healthcare services, particularly in rural or underserved areas. The key market players are Nucleous Telemedicine LLC, Telemedicine.ae, GulfHealth, Advanced Radiology Centre, Global Diagnostics, Telemedico, Prime Diagnostic Centre, Alemadi Radiology, MediGence, TeleRad Providersand others.
UAE Patient Engagement Solutions Market Analysis
The UAE patient engagement solutions market is projected to grow from $85.05 Mn in 2022 to $229.32 Mn by 2030, registering a CAGR of 13.2% during the forecast period of 2022 - 2030. The main factors driving the growth would be high healthcare expenditure, rising chronic disease burden, focus on preventive care and government support. The market is segmented by component, delivery mode, application, therapeutic area, functionality and by end-user. Some of the major players include Okadoc, Healthigo, Orion Health, IBM and Mckesson.
UAE Palliative Care Market Analysis
The UAE Palliative care market is projected to grow from $65.4 Mn in 2022 to $130.31 Mn by 2030, registering a CAGR of 9% during the forecast period of 2022 - 2030. The main factors driving the growth would be the aging population, increasing chronic diseases, and government support. The market is segmented by service type and by the end user. Some of the major players include Eureka Home Health Care, Health2Home, Manzil Healthcare Services, Aster DM Healthcare, and Burjeel Hospital.
UAE Neurology Devices Market Analysis
UAE Neurology Device Market size is at around $63.11 Mn in 2022 and is projected to reach $123.92 Mn in 2030, exhibiting a CAGR of 8.3% during the forecast period. Aspiring to be the center of medical excellence in surgical and non-invasive interventions in the gulf region the increasing prevalence of neurological diseases drive the demand. Major players like Abu Dhabi Medical Devices Company, Atlas Medical Group, Al Naghi Medical, and Kiwi Medical Supplies are giants in neurology devices. This report by Insights10 is segmented by product type like neurostimulation, interventional neurology, neurosurgery devices, and neuro-endoscopes, and by the end user.
UAE Cancer Pain Management Market Analysis
The UAE Cancer Pain Management market is projected to grow from $32.6 Mn in 2022 to $53.15 Mn by 2030, registering a CAGR of 6.3% during the forecast period of 2022-2030. The main factors driving the growth would be the increasing incidence of cancers, growing awareness, advanced healthcare infrastructure, and government support. The market is segmented by drug type and by disease. Some of the major players include Neopharma (ARE), NewBridge Pharmaceuticals (ARE), Abbott, Pfizer, and Johnson & Johnson.
UAE Orphan Diseases Drugs Market Analysis
The UAE Orphan Diseases Drugs Market is projected to grow from $0.774 Bn in 2022 to $1.823 Bn by 2030, registering a CAGR of 11.30% during the forecast period of 2022 - 2030. UAE has a large patient population with rare diseases, and a growing elderly population is increasing the demand for treatments for these conditions Some of the leading players in the market include Pfizer, Sanofi, Roche, and Novartis.